Axiora Medical Axiora Medical

Orthopedic Instrument Manufacturers & Suppliers

Delivering high-precision, FDA-aligned surgical instrumentation systems and implants optimized for the fast-evolving healthcare landscape of the United States.

Send Inquiry Now

The Landscape of US Orthopedic Care & Supply Chains

The United States represents the largest, most demanding market for orthopedic medical devices globally. The rapid growth of Ambulatory Surgical Centers (ASCs), driven by Medicare cost reimbursement changes and patient preference for outpatient joint replacement and trauma surgeries, has reshaped device acquisition strategies. ASCs operate on lean financial margins, requiring suppliers to deliver not only high-performing, FDA-cleared implants but also reliable, cost-effective orthopedic instrument sets.

At the same time, the transition from traditional reusable sterilization trays to sterile, single-use, pre-packaged instrument kits is accelerating across North American clinics. This shift significantly reduces the overhead of hospital sterile processing departments (SPD), limits cross-contamination risks, and streamlines operational logistics. Suppliers must balance micro-tolerance engineering with robust supply-chain agility to maintain compliance with strict ASTM standards (such as ASTM F136 for titanium alloy implants) and continuous FDA Quality System Regulations (21 CFR Part 820).

Key US Market Requirements

  • Biocompatible Materials: ISO 10993 compliance, utilizing certified medical-grade raw materials (Titanium, cobalt-chrome, and PEEK).
  • UDI & Traceability: Every component marked with unique device identifiers in alignment with FDA's GUDID mandates.
  • Sterilization Validation: Support for steam autoclaving, Gamma, and EtO validation protocols.
  • OEM Adaptability: Capability to manufacture proprietary designs under strict non-disclosure agreements (NDA).

18,600m²

State-of-the-Art Factory Area

USD 26M

Annual Global Export Revenue

86

Expert R&D Engineers

100%

OQC Finished Inspection Rate

Supply Chain Resilience & Efficiency Advantage

Combining advanced manufacturing with scalable logistics to insulate distributors from raw material volatility and production bottlenecks.

Advanced Manufacturing Base

Our facility houses high-precision CNC longitudinal cutters, multi-axis machining centers, and automated polishing setups to manufacture complex geometrical implants with tolerances under 5 microns.

Double-Layer QC Validation

Operating with 48 dedicated quality inspectors. We perform 100% incoming material inspections and exhaustive final checks using CMM, tensile tester machines, and penetrant testing.

Optimized Lead Times

By coordinating production batches, we significantly compress development time for customized OEM/ODM surgical components. Providing North American clients with DDP delivery avenues.

End-to-End Precision Manufacturing Process

A structured, ISO-compliant flow designed to guarantee structural integrity, visual finish, and biological safety for implantable devices.

Axiora's Quality Infrastructure

As an industry-leading orthopedic manufacturer, we base our growth on solid metrological verification. Our facility is equipped with ISO 13485:2016-certified laboratories to perform static and dynamic mechanical stress fatigue test profiles.

Parameters Methods / Standards
Tensile Strength ASTM E8/E8M standard test procedures
Fatigue Limits ASTM F1717 (Spine), ASTM F382 (Bone Plates)
Dimensional Variance Hexagon Coordinate Measuring Machines (CMM)
Surface Quality Roughness testers, target Ra ≤ 0.4 µm prior to anodizing

Technological Roadmap & Next-Gen Innovations

The orthopedic field is moving quickly toward intelligent systems. Axiora's forward-looking R&D focuses on integration within clinical digital networks. Our product development pipeline includes the implementation of passive RFID and data matrix code markings directly on instrument cassettes, matching the demands of smart sterile storage networks across regional US hospitals.

Furthermore, we are expanding our research into 3D-printed porous titanium constructs. This technique mimics human trabecular structures to improve initial osteointegration. By combining selective laser melting (SLM) technologies with traditional CNC milling processes, we produce hybrid implant solutions that reduce surgery times and improve overall patient outcomes.

Company Profile & Operations Overview

Axiora Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments.

Profile Parameter Operational Details
Company Name Axiora Medical Technology (China) Co., Ltd.
Brand & Identity Axiora (www.axioraortho.com)
Established Year 2017 (Featuring over 15 years of industry experience)
Production Capacity 18,600 m² operating space with 86 core R&D engineers
Global Reach USD 26 Million in annual export revenue across North America, Europe, and South America
Inspection Standard 100% Finished Product Inspection, including CMM, hardness, roughness & salt spray tests
Customization Level Comprehensive OEM/ODM, private labeling, laser marking, and customized packaging
New Innovations 126 new orthopedic designs developed and launched in the last calendar year

Frequently Asked Questions

Detailed explanations regarding regulatory compliance, quality validation, and supply logistics for US distributors.

Q1: What materials are utilized in Axiora's orthopedic implants and instrument sets?
Our orthopedic implants are manufactured from certified biocompatible materials, primarily medical-grade Titanium Alloy (Ti-6Al-4V ELI) conforming to ASTM F136 specifications, and implant-grade Polyetheretherketone (PEEK) conforming to ASTM F2026. For surgical instrument kits, we utilize high-temper surgical-grade stainless steels (such as 17-4 PH, 420, and 304 series) to ensure excellent corrosion resistance and mechanical strength through repeated autoclave sterilization cycles.
Q2: How does Axiora ensure compliance with FDA and international quality standards?
Axiora operates under a strict Quality Management System certified to ISO 13485:2016 standards. Our production processes are designed to align with FDA Quality System Regulations (21 CFR Part 820). We conduct 100% finished product inspections, including coordinate measuring machine (CMM) dimensional verification, tensile strength testing, surface roughness analysis, and dye penetrant inspection in our ISO Class 7 cleanrooms to guarantee zero defect shipments.
Q3: Can Axiora provide customized OEM/ODM design services and custom labeling?
Yes. Backed by an active R&D division of 86 engineers, we offer extensive OEM/ODM services. We can manufacture components directly from customer-supplied 2D/3D CAD drawings or physical samples. Our services include private labeling, laser-marking Unique Device Identifiers (UDI), custom sterile packaging, and developing customized surgical instrumentation trays configured to specific clinical requirements.
Q4: What is the typical lead time for deliveries to the United States market?
For standard inventory orthopedic instruments, shipments can be dispatched within 7–10 business days. For customized OEM runs or bulk production orders, our lead times typically range from 30 to 60 days, depending on geometry complexity and quantity requirements. We offer multiple shipping channels, including air freight, sea freight, and direct DDP courier shipping to expedite import and custom clearance processes.

Begin Your Custom Procurement Evaluation

Connect with our technical R&D and supply chain management teams today. Receive standard catalogs or request custom OEM component manufacturing quotes.

Send Inquiry Now